{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:56Z","timestamp":1790516156403,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>\n                    Within the kidney, the (pro)renin receptor (PRR) is predominantly expressed in the collecting duct (CD), particularly in intercalated cells, and it is regulated by the PGE\n                    <jats:sub>2<\/jats:sub>\n                    receptor EP\n                    <jats:sub>4<\/jats:sub>\n                    . Notably, EP\n                    <jats:sub>4<\/jats:sub>\n                    also controls urinary concentration through regulation of aquaporin 2 (AQP2). Here, we tested the hypothesis that sequential activation of EP\n                    <jats:sub>4<\/jats:sub>\n                    and PRR determines AQP2 expression in the CD, thus mediating the antidiuretic action of vasopressin (AVP). Water deprivation (WD) elevated renal PRR expression and urinary soluble PRR excretion in rats. Intrarenal infusion of a PRR decoy peptide, PRO20, or an EP\n                    <jats:sub>4<\/jats:sub>\n                    antagonist partially prevented the decrease in urine volume and the increase in urine osmolality and AQP2 expression induced by 48-hour WD. In primary cultures of rat inner medullary CD cells, AQP2 expression induced by AVP treatment for 24 hours depended on sequential activation of the EP\n                    <jats:sub>4<\/jats:sub>\n                    receptor and PRR. Additionally, mice lacking PRR in the CD exhibited increased urine volume and decreased urine osmolality under basal conditions and impaired urine concentrating capability accompanied by severe volume loss and a dangerous level of plasma hyperosmolality after WD. Together, these results suggest a previously undescribed linear AVP\/PGE\n                    <jats:sub>2<\/jats:sub>\n                    \/EP\n                    <jats:sub>4<\/jats:sub>\n                    \/PRR pathway in the CD for regulation of AQP2 expression and urine concentrating capability.\n                  <\/jats:p>","DOI":"10.1681\/asn.2015050592","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T23:44:19Z","timestamp":1458603859000},"page":"3022-3034","source":"Crossref","is-referenced-by-count":79,"title":["Antidiuretic Action of Collecting Duct (Pro)Renin Receptor Downstream of Vasopressin and PGE2 Receptor EP4"],"prefix":"10.1681","volume":"27","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;"},{"name":"Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[{"name":"Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Su","sequence":"additional","affiliation":[{"name":"Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Nau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Endocrinology and Hypertension, Tokyo Women\u2019s Medical University, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Lu","sequence":"additional","affiliation":[{"name":"Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Feng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;"},{"name":"Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"B1-20231016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney: From molecules to medicine.","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol Rev"},{"key":"B2-20231016","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1172\/JCI39680","article-title":"A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus.","volume":"119","author":"Li","year":"2009","journal-title":"J Clin Invest"},{"key":"B3-20231016","doi-asserted-by":"crossref","first-page":"F1001","DOI":"10.1152\/ajprenal.2001.280.6.F1001","article-title":"Localization of prostaglandin E(2) EP2 and EP4 receptors in the rat kidney.","volume":"280","author":"Jensen","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0090-6980(81)90088-5","article-title":"Distribution of prostaglandin E2-sensitive adenylate cyclase along the rat nephron.","volume":"21","author":"Torikai","year":"1981","journal-title":"Prostaglandins"},{"key":"B5-20231016","doi-asserted-by":"crossref","first-page":"F746","DOI":"10.1152\/ajprenal.00644.2011","article-title":"AT1a receptor signaling is required for basal and water deprivation-induced urine concentration in AT1a receptor-deficient mice.","volume":"303","author":"Li","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"B6-20231016","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin.","volume":"109","author":"Nguyen","year":"2002","journal-title":"J Clin Invest"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"R274","DOI":"10.1152\/ajpregu.00439.2005","article-title":"Renin receptor expression in human adipose tissue.","volume":"292","author":"Achard","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B8-20231016","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1074\/jbc.273.18.10939","article-title":"Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules.","volume":"273","author":"Ludwig","year":"1998","journal-title":"J Biol Chem"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.HYP.0000240064.19301.1b","article-title":"Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II.","volume":"48","author":"Saris","year":"2006","journal-title":"Hypertension"},{"key":"B10-20231016","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/HYPERTENSIONAHA.109.128645","article-title":"The (Pro)renin receptor: Site-specific and functional linkage to the vacuolar H+-ATPase in the kidney.","volume":"54","author":"Advani","year":"2009","journal-title":"Hypertension"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/HYPERTENSIONAHA.112.196303","article-title":"Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (Pro)renin receptor in rat renal inner medullary cells.","volume":"61","author":"Gonzalez","year":"2013","journal-title":"Hypertension"},{"key":"B12-20231016","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1152\/ajprenal.00548.2013","article-title":"COX-2 mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.","volume":"307","author":"Wang","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/HYPERTENSIONAHA.114.03654","article-title":"Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.","volume":"64","author":"Wang","year":"2014","journal-title":"Hypertension"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.114.04458","article-title":"Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.","volume":"65","author":"Li","year":"2015","journal-title":"Hypertension"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.108.127258","article-title":"Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma.","volume":"53","author":"Cousin","year":"2009","journal-title":"Hypertension"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/hr.2010.284","article-title":"The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion into extracellular space.","volume":"34","author":"Yoshikawa","year":"2011","journal-title":"Hypertens Res"},{"key":"B17-20231016","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/HYPERTENSIONAHA.111.190108","article-title":"Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension.","volume":"59","author":"Li","year":"2012","journal-title":"Hypertension"},{"key":"B18-20231016","first-page":"F3","article-title":"Molecular physiology of urinary concentrating mechanism: Regulation of aquaporin water channels by vasopressin.","volume":"272","author":"Knepper","year":"1997","journal-title":"Am J Physiol"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","article-title":"Physiological regulation of prostaglandins in the kidney.","volume":"70","author":"Hao","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1139\/y95-026","article-title":"Functional and molecular aspects of prostaglandin E receptors in the cortical collecting duct.","volume":"73","author":"H\u00e9bert","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"B21-20231016","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1073\/pnas.1104691108","article-title":"Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.","volume":"108","author":"Olesen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22-20231016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1681\/ASN.2012020217","article-title":"Is there a role for PGE2 in urinary concentration?","volume":"24","author":"Olesen","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B23-20231016","first-page":"169","article-title":"Prostaglandins and the kidney.","volume":"233","author":"Dunn","year":"1977","journal-title":"Am J Physiol"},{"key":"B24-20231016","first-page":"F257","article-title":"Luminal prostaglandin E receptors regulate salt and water transport in rabbit cortical collecting duct.","volume":"269","author":"Sakairi","year":"1995","journal-title":"Am J Physiol"},{"key":"B25-20231016","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/en.2012-2074","article-title":"TGF-\u03b2 effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K\/AKT\/mTOR pathway.","volume":"154","author":"Vo","year":"2013","journal-title":"Endocrinology"},{"key":"B26-20231016","doi-asserted-by":"crossref","first-page":"F756","DOI":"10.1152\/ajprenal.00728.2009","article-title":"Inducible renal principal cell-specific mineralocorticoid receptor gene inactivation in mice.","volume":"300","author":"Ronzaud","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B27-20231016","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.1998.275.1.C216","article-title":"Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive system of transgenic mice.","volume":"275","author":"Nelson","year":"1998","journal-title":"Am J Physiol"},{"key":"B28-20231016","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1470320310391327","article-title":"Higher levels of prorenin predict development of diabetic retinopathy in patients with type 2 diabetes.","volume":"12","author":"Yokota","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"B29-20231016","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/HYPERTENSIONAHA.107.107268","article-title":"The collecting duct is the major source of prorenin in diabetes.","volume":"51","author":"Kang","year":"2008","journal-title":"Hypertension"},{"key":"B30-20231016","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0501744102","article-title":"Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31-20231016","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1172\/JCI200421064","article-title":"Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention.","volume":"114","author":"Ahn","year":"2004","journal-title":"J Clin Invest"},{"key":"B32-20231016","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","article-title":"Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.","volume":"11","author":"Guan","year":"2005","journal-title":"Nat Med"},{"key":"B33-20231016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1681\/ASN.2012080866","article-title":"Aqp2-expressing cells give rise to renal intercalated cells.","volume":"24","author":"Wu","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B34-20231016","first-page":"F1","article-title":"Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro.","volume":"277","author":"Yang","year":"1999","journal-title":"Am J Physiol"},{"key":"B35-20231016","doi-asserted-by":"crossref","first-page":"23281","DOI":"10.1074\/jbc.M910237199","article-title":"MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells.","volume":"275","author":"Yang","year":"2000","journal-title":"J Biol Chem"},{"key":"B36-20231016","doi-asserted-by":"crossref","first-page":"34966","DOI":"10.1074\/jbc.M502430200","article-title":"Hypertonic induction of COX-2 in collecting duct cells by reactive oxygen species of mitochondrial origin.","volume":"280","author":"Yang","year":"2005","journal-title":"J Biol Chem"},{"key":"B37-20231016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00041552-200001000-00005","article-title":"Prostaglandin receptors: Their role in regulating renal function.","volume":"9","author":"Breyer","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B38-20231016","doi-asserted-by":"crossref","first-page":"F607","DOI":"10.1152\/ajprenal.2001.280.4.F607","article-title":"Renal concentrating defect in mice lacking group IV cytosolic phospholipase A(2).","volume":"280","author":"Downey","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"B39-20231016","doi-asserted-by":"crossref","first-page":"F1303","DOI":"10.1152\/ajprenal.00665.2010","article-title":"COX-2 disruption leads to increased central vasopressin stores and impaired urine concentrating ability in mice.","volume":"301","author":"N\u00f8rregaard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B40-20231016","doi-asserted-by":"crossref","first-page":"F1051","DOI":"10.1152\/ajprenal.90202.2008","article-title":"Dehydration-induced increase in aquaporin-2 protein abundance is blocked by nonsteroidal anti-inflammatory drugs.","volume":"298","author":"Baggaley","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"B41-20231016","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00045391-200007030-00004","article-title":"Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.","volume":"7","author":"Whelton","year":"2000","journal-title":"Am J Ther"},{"key":"B42-20231016","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2826.2010.01980.x","article-title":"Expression of (pro)renin receptor in the human brain and pituitary, and co-localisation with arginine vasopressin and oxytocin in the hypothalamus.","volume":"22","author":"Takahashi","year":"2010","journal-title":"J Neuroendocrinol"},{"key":"B43-20231016","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1152\/ajpregu.00209.2013","article-title":"The (pro)renin receptor and body fluid homeostasis.","volume":"305","author":"Cao","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B44-20231016","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCRESAHA.110.226977","article-title":"Involvement of the brain (pro)renin receptor in cardiovascular homeostasis.","volume":"107","author":"Shan","year":"2010","journal-title":"Circ Res"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201610000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:27:42Z","timestamp":1786130862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201610000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2015050592","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726230516.793523723","asserted-by":"object"}]},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}